Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04434495
Other study ID # DrOsmanH
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date June 15, 2020
Est. completion date April 15, 2021

Study information

Verified date June 2020
Source Dr. Osman Hospital
Contact Hisham Gouda, MD
Phone 00201001885885
Email Sheemer75@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

2 groups randomized to PRP injectioninto uterine cavity at mock embryo transfer, and a control group with only mock embryo transfer.


Description:

Participants are allocated in two groups ( randomized). Study is conducted in Dar El Teb infertility and IVF centre, Egypt. Normoresponder patients (9-15 mature follicles on day of HCG administration) and candidates for fresh embryo transfer are recruited to the study. 788 patients will be randomized on the day of ovum pick up in a 1 to 1 ratio to platelet rich plasma (PRP) group and control group. Patients wee randomized using computer generated randomization list and sequentially numbered sealed envelopes containing allocation information written on a card. The embryologist and doctors responsible for follow up after ovum pick up aew blinded to received treatment. Ovarian stimunlation is achieved by highly purified urinary FSH (Fostimon, IBSA, Switzerland)started on the 2nd or 3rd day of menstruation. The initial dose ranged between 150-300IU/d depending on expected ovarian response and serum E2 level. GnRH antagonist (Cetrotide, Serono international, Geneva, Switzerland) 0.25mgSC/day will be give when the leading follicle is 14mm and continued till day of HCG. 10,000 IU HCG will be given when 3 or more follicles are 18mm on mean diameter. Oocyte retrieval will be performed 34-36 hours after HCG administration. In PRP group, 1 ml autologous PRP prepared from blood of participants and injected under ultrasound guidance inside the uterus while performing the mock embryo transfer. In control group, mock embryo transfer was performed without injecting anything inside the uterus. All participants will receive progesterone vaginal pessaries (Prontogest, Marcyrl, Egypt) 400 mg twicw daily, starting on day of oocyte retrieval till 12weeks gestation or negative pregnancy test. No more than 3 embryos will be transferred2-5 days after oocyte retrival. B HCG levels will be measured in blood 14 days after HCGadministration. Transvaginal ultrasound will be performed 4 weeks after embryo transfer to confirm clinical pregnancy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 788
Est. completion date April 15, 2021
Est. primary completion date November 15, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Normoresponder patients (i.e. patients with 9 to 15 mature follicles on the day of HCG administration ) with expected good reproductive outcomes of IVF-ET and candidates for fresh embryo transfer

Exclusion Criteria:

- Age less than 18 years and more than 35 years Body mass index more than 30kg/m2 Serum progesterone level less than 1.5 ng/ml on the trigger day Smoking Moreover, patients with previous IVF cycle, PCOS ( polycystic ovarian syndrome), pelvic inflammatory disease, endometriosis, uterine anomalies, Ashermann syndrome, chronic endometritis, chromosomal anomalies, increased peripheral NK cells, hereditary thrombophylia and antiphospholipid syndrome were excluded from the study

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
PRP
PRP injection into uterine cavity

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Dr. Osman Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy rate The presence of gestational sac by transvaginal ultrasound Four weeks post intervention
Secondary Implantation rate The number of gestational sacs detected by ultrasound divided by the number of embryos transferred Four weeks post intervention
Secondary Ongoing pregnancy rate Number of continued pregnancies beyond 20 weeks gestation Five months post intervention
Secondary Abortion rate Number of pregnancies terminated before 20 weeks gestation Five months post intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06313112 - Impact of Food Insecurity on Utilization of Maternal Healthcare Services and Birth Outcomes in Slums in Pune, India
Recruiting NCT03242746 - Cervical Morphological Changes on Pregnancy Outcome
Recruiting NCT04515134 - Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI
Completed NCT03740568 - Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes. N/A
Completed NCT05355038 - Effect of Lifestyle Modification on Pregnancy Outcome for GDM N/A
Recruiting NCT05506631 - Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening N/A
Terminated NCT03489174 - Routine Pregnancy Screening for Women on Opioid Substitution Therapy N/A
Completed NCT03748576 - A Prospective Randomized Controlled Trial of Mobile Medical Used for Management of Pregnant Women N/A
Active, not recruiting NCT03113331 - The 3D Cohort Study (Design, Develop, Discover)
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)
Recruiting NCT04930276 - Diet-glucose-gut Microbiome Net in Women With GDM N/A
Enrolling by invitation NCT04977466 - NIH Intramural Research Program s Pregnancy Registry Protocol for Subjects and Their Partners
Withdrawn NCT05847140 - A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy
Active, not recruiting NCT02271490 - Acrosome Reaction Induction Prior to ICSI N/A
Not yet recruiting NCT04434547 - A RCT on the Effect of Platelets Rich Plasma in ICSI Patients With Recurrent Implantation Failure Phase 2
Completed NCT05647538 - Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome
Completed NCT00878098 - Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
Completed NCT01653392 - BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Recruiting NCT05733377 - Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome
Not yet recruiting NCT05457335 - 2.Comparison of the Live Birth Rate of PGT Versus Expectant Management in Patients With RPL